Novel Calculators for Risk Stratification in Hepatocellular Carcinoma: A Concise Review

Mario Pirisi1, Monica Leutner2, Raffaele Romito3

  • 1Department of Translational Medicine (DiMeT), University of Eastern Piedmont.

Insights

This review highlights 10 free online calculators for hepatocellular carcinoma (HCC) risk and prognosis. Many clinicians may be unaware of these valuable tools for managing liver cancer.

Area of Science:

  • Hepatology
  • Medical Informatics
  • Oncology

Background:

  • Medical calculators are increasingly used by clinicians, but awareness of their existence and utility varies.
  • Many healthcare professionals may be unaware of specialized medical calculators relevant to their practice.
  • This gap in awareness might extend to tools for hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To identify and review free online medical calculators for hepatocellular carcinoma (HCC).
  • To categorize HCC calculators based on their application (risk assessment or prognostication).
  • To assess the impact and adoption of these calculators within the medical community.

Main Methods:

  • A concise review of 10 free online medical calculators developed within the last 8 years.
  • Categorization of calculators into two groups: HCC risk (N=4) and HCC prognostication (N=6).
  • Evaluation of calculator success based on inclusion in popular medical calculator apps and citation frequency in scientific literature.

Main Results:

  • Ten free online medical calculators for HCC were identified and reviewed.
  • Four calculators focused on HCC risk assessment, and six focused on prognostication for established HCC.
  • Calculator adoption was assessed via app inclusion and citation metrics.

Conclusions:

  • A significant number of free online medical calculators for HCC exist, aiding in risk assessment and prognostication.
  • Awareness of these tools among clinicians may be suboptimal.
  • Further dissemination and integration of these calculators into clinical practice are warranted.